## **Connie Medical Chair – Activities Summary (2024 – 2025)**
During this period, the Connie Medical Chair charity continued progressing the design, development and fundraising for a specialist medical chair intended to improve the wellbeing of children in intensive and palliative care settings.
A major focus has been advancing the product from concept toward prototype stage. Working closely with engineering partners at One/Three (now Heavy Industry), the design moved through regulatory review, block modelling and detailed design phases. Following finalisation of the core structure, prototype manufacturing was initiated, including overseas component production. Although delays occurred due to part amendments and international reprinting requirements, the prototype is now nearing completion, with final adjustments relating to straps and padding ongoing. Specialist advice has been sought from infection control professionals to ensure compliance with clinical hygiene standards, and further consultation with textile manufacturers is underway to finalise safe and durable materials.
Financially, the charity has maintained careful stewardship of resources while investing in prototype development. Over the reporting period, significant design and prototype payments were made, including manufacturing, VAT and import duties. Fundraising activity included church-based collections, a funeral donation, individual gifts, and online giving via the Kindlink platform. The All Saints Christmas Carol Service generated over £1,500, alongside additional individual donations and Gift Aid claims. The current account balance remains stable, reflecting both prudent financial management and targeted expenditure on development milestones.
Governance and infrastructure have also progressed. The charity continued to operate its Kindlink donation and Gift Aid systems and secured Google Non-Profit status, enabling access to digital tools and potential advertising grants to support future fundraising campaigns. Trustee engagement and engineering support remain active, with discussions ongoing regarding formal trustee appointments and freelance technical support.
Looking ahead, priorities include finalising the prototype (including straps and seat padding), engaging hospital stakeholders for feedback, and launching a more focused fundraising campaign supported by community events and digital promotion. Potential fundraising opportunities include church events, a pub fundraiser, and participation in sponsored events.
Overall, despite personal commitments and some manufacturing delays, steady progress has been made toward delivering a clinically informed prototype and strengthening the charity’s fundraising and operational foundations.
Signed Rick Williams – Chair of Trustees
|**Charity Name**||**No (if any)**|||
|---|---|---|---|---|
|**Connie Medical Chair**||**1202127**|||
|**Receipts andpayments accounts**||||**CC16a**|
|**For the period**
**from**|01/07/2024
Period start date|30/06/2025
Period end date
**To**|||
|**Section A Receipts and payments**|**Section A Receipts and payments**||||||
|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**4,695**
**388**
**-**
**-**
**-**
**-**
**-**
**-**
**5,083**
**-**
**-**
**-**
**5,083**
**1,813**
**369**
**500**
**-**
**2,681**
**-**
**-**
**-**
**2,681**
**2,401**
**-**
**-**
**2,401**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**4,695**
**388**
**-**
**-**
**-**
**-**
**-**
**-**
**5,083**
**-**
**-**
**-**
**5,083**
**-**
**1,813**
**-**
**-**
**369**
**-**
**-**
**500**
**-**
**2,681**
**-**
**-**
**-**
**2,681**
**2,401**||**Last year**
**to the nearest £**|
|Donations|**4,695**|||||**22,292**|
|Gift Aid collection|**388**|||||**1,657**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|
**5,083**|||||**23,949**|
||||||||
|**A2 Asset and investment sales,**
**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**
**A3 Payments**|||||||
|||||||**23,949**|
||||||||
|
Cost of fundraisingactivities||||||**600**|
|Costs of charitable activities|**1,813**|||||**19,849**|
|Postage||||||**4**|
|Advertisingand marketing||||||**105**|
|Subscriptions|**369**|||||**286**|
|Travel||||||**166**|
|Bank fees||||||**17**|
|AccountancyFees|**500**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**2,681**|||||**21,027**|
||||||||
|**A4 Asset and investment**
**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||
|||||||**21,027**|
||||||||
||**2,401**|**-**|**-**|**2,401**||**2,922**|
||**-**|**-**|**-**|**-**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**2,401**|**-**|**-**|**2,401**||**2,922**|
CCXX R1 accounts (SS)
24/03/2026
1
|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|
|**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Accountancy fee
Independent Examiner fee
**Details**
**Details**
Metro bank account
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**to nearest £**
**5,324**
**-**
**-**
**5,324**
Agreement Error
**Unrestricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Fund to which**
**asset belongs**
**Fund to which**
**liability relates**
Unrestricted
Unrestricted|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Amount due**
**(optional)**
**350**
**150**
**-**
**-**
**-**|**Endowment funds**
**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**Endowment funds**
**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value (optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value (optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**When due (optional)**|
||Accountancy fee|
Unrestricted|**350**|**When accounts**
**completed**|
||Independent Examiner fee|Unrestricted|**150**|**When accounts**
**completed**|
||||**-**||
||||**-**||
||||**-**||
Signed by one or two trustees on behalf of all the trustees
||||
|---|---|---|
|Signature|Print Name
Richard Williams|Date of approval|
||Richard Williams|24/03/2026|
||||
CCXX R2 accounts (SS)
24/03/2026
2